Waters Corporation

WAT

US9418481035

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 16:00:02 2024-07-16 EDT			5-day change	1st Jan Change
316.7 ^USD	+4.56%		+11.93%	-3.80%

07-15	TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating	MT
07-02	Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating	MT

Waters Corporation authorizes a Buyback Plan.

January 20, 2019

The Board of Directors of Waters Corporation has authorized a buyback plan on January 21, 2019.

Latest news about Waters Corporation

TD Cowen Adjusts Price Target on Waters to $325 From $358, Maintains Hold Rating	07-15	MT
Evercore ISI Adjusts Price Target on Waters to $300 From $320, Maintains In-Line Rating	07-02	MT
Waters Corporation(NYSE:WAT) added to Russell Midcap Value Index	06-30	CI
Waters Corporation(NYSE:WAT) added to Russell 3000 Value Index	06-30	CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value-Defensive Index	06-30	CI
Waters Corporation(NYSE:WAT) added to Russell 1000 Value Index	06-30	CI
Waters Corporation(NYSE:WAT) added to Russell 3000E Value Index	06-30	CI
Barclays Adjusts Price Target on Waters to $275 From $295	06-27	MT
Transcript : Waters Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM	06-05
Waters Insider Bought Shares Worth $332,900, According to a Recent SEC Filing	05-29	MT
Deutsche Bank Adjusts Waters Price Target to $330 From $304	05-22	MT
Waters Corp Insider Sold Shares Worth $1,446,560, According to a Recent SEC Filing	05-16	MT
Bernstein Adjusts Price Target on Waters to $307 From $304	05-08	MT
JPMorgan Adjusts Price Target on Waters to $315 From $300	05-08	MT
TD Cowen Adjusts Price Target on Waters to $358 From $350	05-08	MT
Stifel Nicolaus Adjusts Waters Price Target to $332 From $330	05-08	MT
Baird Adjusts Waters Price Target to $312 From $319	05-08	MT
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip	05-07	RE
Barclays Lowers Waters' Price Target to $295 From $300	05-07	MT
Evercore IS Adjusts Waters' Price Target to $320 From $340, Keeps In Line Rating	05-07	MT
Waters Seeks M&A Opportunities	05-07	CI
Transcript : Waters Corporation, Q1 2024 Earnings Call, May 07, 2024	05-07
Waters' Q1 Non-GAAP Earnings, Net Sales Decline; Q2 Outlook Issued	05-07	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Revenue $636.8M	05-07	MT
Earnings Flash (WAT) WATERS CORPORATION Reports Q1 Adjusted EPS $2.21	05-07	MT

Waters Corporation specializes in the conception, the manufacturing and the marketing of analytical instruments. Net sales break down by activity as follows: - sale of instruments and analytical systems (63.6%): chromatographic analysis instruments (59.5% of net sales; instruments high performance liquid chromatography and mass spectrometry), chemistry consumables (28.9%; including columns chemical separation) and thermal analysis, rheometry and calorimetry instruments (11.6%) ; - services (36.7%): support services, training, etc. Net sales are distributed by market between pharmaceutical (58.6%), industrial (29.9%), academic institutions and governmental agencies (11.4%). Net sales are distributed geographically as follows: the United States (28.7%), Americas (5.1%), China (17.1%), Japan (7.6%), Asia (13.3%) and Europe (28.2%).

Sector

Advanced Medical Equipment & Technology

Calendar

2024-07-31 - Q2 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Waters Corporation

Trading Rating

Investor Rating

ESG Refinitiv

A-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

316.7 USD

Average target price

321 USD

Spread / Average Target

+1.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
WATERS CORPORATION	-3.80%	18.79B
THERMO FISHER SCIENTIFIC	+4.64%	212B
DANAHER CORPORATION	+8.99%	187B
INTUITIVE SURGICAL, INC.	+29.83%	155B
BOSTON SCIENTIFIC CORPORATION	+35.17%	115B
SIEMENS HEALTHINEERS AG	+1.67%	65.5B
EDWARDS LIFESCIENCES CORPORATION	+15.06%	52.87B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	45.25B
AGILENT TECHNOLOGIES, INC.	-2.14%	39.7B
GE HEALTHCARE TECHNOLOGIES INC.	+6.88%	37.72B

Other Advanced Medical Equipment & Technology